Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Selection dynamics of HCV genotype 3 resistance-associated substitutions under direct-acting antiviral therapy pressure
João Paulo Vilela Rodrigues; Guilherme Rodrigues Fernandes Campos; Cintia Bittar; Ana de Lourdes Candolo Martinelli; Marília Silveira de Almeida Campos; Leonardo Régis Leira Pereira; Paula Rahal; Fernanda Fernandes Souza;
Braz J Infect Dis. 2022;26:
Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study
Gustavo H. Pereira; Helena R. Peixoto; Mariana L. Giusti; Mariana L. Souza; Livia B. Victor; Flávia Fernandes; Renata M. Perez; Cristiane A. Villela-Nogueira;
Braz J Infect Dis. 2022;26:
A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil
Simone Monzani Vivaldini; Rachel Abraão Ribeiro; Gláucio Mosimann Júnior; Karen Cristine Tonini; Gerson Fernando Mendes Pereira; Wildo Navegantes de Araújo;
Braz J Infect Dis. 2021;25: